Printer Friendly

A New Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is now at

AUSTIN, Texas --, Inc. announced today that a new audio interview with BioElectronics Corp. (Pinksheets:BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices is now available. The interview can be heard at In the interview, CEO, Andrew Whelan, discusses the Company's schedule for FDA applications for its drug-free anti-inflammatory devices and reiterates his confidence relative to FDA OTC clearances. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. Tools like stock charts, stock alerts, and investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch[R] Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy ( and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see

This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 8, 2009
Previous Article:Univa Announces Integration With OpenSolaris Operating System.
Next Article:TeamF1 Announces Support for Cavium Networks' ECONA Family of ARM[R]-Based Energy Efficient System-on-Chip (SoC) Processors for the Digital Home.

Related Articles
Thomas O'Connor, Executive VP of Operations, COO and CFO of BioElectronics, is Featured in an Audio Interview at
BioElectronics Corp. to Appear on
A New Audio Interview Featuring Joe Noel of BioElectronics Corp. is now at
In a New Interview, Joe Noel of BioElectronics Corp. Discusses Implications of Recent FDA Acetaminophen Meetings.
Emerging Growth Research Analyst, Joe Noel, Discusses EFT BioTech Holdings, Inc. in Audio interview at
A New Audio Interview Featuring The Aerospace Corporation and TIE Technologies is Now Available at
In a New Interview, Joe Noel of BioElectronics Corp. Updates Shareholders on Strengthened Balance Sheet and FDA Applications.
A New Audio Interview with Joe Riehl, CEO of Metatron, Inc., is now at
A New Audio Interview with Carrie Snyder, Independent Analyst Covering BioElectronics Corp., is now at
Joe Riehl, CEO of Metatron, Inc., Provides a Significant Progress Report in a New Audio Interview at

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters